In the journal The Lancet, DZIF researchers from the Research Center Borstel and their colleagues from England and South Africa make the case for optimising tuberculosis drug development. They
From chemistry to biology to medicine—during the course of his career, Mark Brönstrup repeatedly crossed the boundaries between these disciplines. So it comes as no surprise that today he is head of
An international group of scientists unraveled for the first time the global spread of multidrug resistant (MDR) Mycobacterium tuberculosis (MTB) strains. The study shows that efficient tuberculosis
An international team of researchers has discovered an antibiotic compound which is effective against a broad spectrum of pathogens. First tests have shown that it does not generate resistance. A
The DZIF Transplant Cohort, which was officially founded as an association in February 2014, has completed its preparations. The association can now begin with recruiting first patients and collecting
Researchers from the German Center for Infection Research (DZIF) have confirmed the spread of a “multidrug-resistant plasmid” in a hospital. This plasmid is a mobile genetic element which can transfer
(26/11/2014) Virologist Stephan Urban from the University of Heidelberg will receive the DZIF Prize for Translational Infection Research, worth 5000 Euros. It will be awarded for the first time at the
Researchers at the University of Tübingen are testing an Ebolavaccine in healthy adults in Gabon. The first voluntary trial participants are being vaccinated today.
A clinical phase I trial for a potential vaccine against the dreaded Ebola virus can now begin. The candidate vaccine has already successfully been tested in different animal models. The trial is
